Skip to main content
SpringerLink
Log in

Surgical treatment of hepatocellular carcinoma with cirrhotic esophageal varices and hypersplenism: a 184 case report

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

In treating hepatocellular carcinoma (HCC) patients with advanced cirrhosis, one of the most difficult problems is concomitant esophageal varices and hypersplenism. Whether these conditions should be treated surgically in association with HCC resection is still in debate. To elucidate whether esophageal devascularization or splenectomy is beneficial when simultaneously performed with liver resection in HCC patients with both varices and hypersplenism, HCC patients (n = 184) with esophageal varices and hypersplenism received one of the three treatments: simultaneous liver resection and esophageal devascularization (Group I, n = 41); simultaneous liver resection and splenectomy (Group II, n = 61); liver resection only (Group III, n = 82). The incidences of postoperative complications of the three groups were 31.7%, 29.5% and 24.4%, respectively, with no significant difference among them. The 5-year tumor-free survival rates for the group I, group II and group III were 34.1%, 36.1% and 37.8%, respectively. Variceal bleeding caused death by only 4.2% in group I, but by 14.3% in group II and 23.2% in group III. The survival rates in the group I and the group II were comparable to those in the group III, however, the recurrences of postoperative fatal variceal bleeding in group I and group II were significantly lower than those in group III. The results suggest that HCC patients with esophageal varices and hypersplenism should undergo hepatic resection plus esophageal devascularization or splenectomy if radical resection of HCC can be expected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen X P, Wu Z D, Qiu F Z. The history, present and prospect of the surgical treatment of primary liver cancer in China. Chin J Bases Clin General Surg, 2000, 7: 257–258

    Google Scholar 

  2. Chen X P, Qiu F Z, Wu Z D, Zhang B X. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg, 2004, 91(3): 322–326

    Article  CAS  PubMed  Google Scholar 

  3. Lau W Y. Management of hepatocellular carcinoma. J R Coll Surg Edinb, 2002, 47: 389–399

    CAS  PubMed  Google Scholar 

  4. Fujisaki S, Miyake H, Amano S, Nakayama H, Tomita R, Fukuzawa M. Influence of the extent of hepatectomy on the portal hypertensive state in patients with hepatoma. Hepatogastroenterology, 1999, 46(28): 2490–2494

    CAS  PubMed  Google Scholar 

  5. Matsumata T, Kanematsu T, Shirabe K, Takenaka K, Kitano S, Sugimachi K. Advances in the treatment of hepatocellular carcinoma and concomitant esophageal varices. Hepatogastroenterology, 1990, 37(5): 461–464

    CAS  PubMed  Google Scholar 

  6. Grazi G L, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, Cavallari A, Mazziotti A. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg, 2001, 234(1): 71–78

    Article  CAS  PubMed  Google Scholar 

  7. Capussotti L, Muratore A, Massucco P, Ferrero A, Polastri R, Bouzari H. Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes. Liver Transplant, 2004, 10(2 Suppl 1): S64–S68

    Article  Google Scholar 

  8. Nagasue N, Kohno H, Yamanoi A, et al. Role of splenectomy in hepatic resection for hepatocellular carcinoma associated with severe cirrhosis and hypersplenism. Hepat Res, 1999, 14: 35–48

    Article  Google Scholar 

  9. Tung-Ping Poon R, Fan S T, Wong J. Risk factors Prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg, 2000, 232(1): 10–24.

    Article  CAS  PubMed  Google Scholar 

  10. Yoo H Y, Patt C H, Geschwidn J F, Thuluvath P J. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1987 and 2001: 5-year survival has improved significantly with time. J Clin Oncol, 2003, 21(23): 4329–4335

    Article  PubMed  Google Scholar 

  11. Makuuchi M, Takayama T, Kubota K, Kimura W, Midorikawa Y, Miyagawa S, Kawasaki S. Hepatic resection for hepatocellular carcinoma: Japanese experience. Hepatogastroenterology, 1998, 45Suppl 3: 1267–1274

    PubMed  Google Scholar 

  12. Fan S T, Lo C M, Liu C L, Lam C M, Yuen W K, Yeung C, Wong J. Hepatectomy for hepatocellular carcinoma toward zero hospital deaths. Ann Surg, 1999, 229(3): 322–330

    Article  CAS  PubMed  Google Scholar 

  13. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology, 1993, 40(4): 328–332

    CAS  PubMed  Google Scholar 

  14. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg, 1995, 19(1): 35–41

    Article  CAS  PubMed  Google Scholar 

  15. Vauthey J N, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg, 1995, 169(1): 28–35

    Article  CAS  PubMed  Google Scholar 

  16. Lin M C, Wu C C, Ho W L, Yeh D C, Liu T J, P’eng F K. Concomitant splenectomy for hypersplenic thrombocytopenia in hepatic resection for hepatocellular carcinoma. Hepatogastroenterology, 1999, 46: 630–634

    CAS  PubMed  Google Scholar 

  17. Lacerda C M, Freire W, Vieira de Melo P S, Lacerda H R, Carvalho G. Splenectomy and ligation of the left gastric vein in schistosomiasis mansoni: the effect on esophageal variceal pressure measured by a non-invasive technique. Keio J Med, 2002, 51(2): 89–92

    Article  PubMed  Google Scholar 

  18. Hirai K, Kawazoe Y, Yamashita K, Kumagai M, Tanaka M, Sakai T, Inoue R, Eguchi S, Majima Y, Abe M, et al. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis. Hepatogastroenterology, 1986, 33(3): 105–108

    CAS  PubMed  Google Scholar 

  19. Lokich J, Costello P. Splenic embolization to prevent dose limitation of cancer chemotherapy. Am J Roentgenol, 1983, 140(1): 159–161

    Article  CAS  Google Scholar 

  20. Yoshimi F, Meigata K, Nagao T, Fukushima S, Uchida H, Wakabayashi T. Hepatocellular carcinoma with a solitary adrenal metastasis and poor hepatic functional reserve: report of a case. Surg Today, 1994, 24(3): 268–271

    Article  CAS  PubMed  Google Scholar 

  21. Shimada M, Hashizume M, Shirabe K, Takenaka K, Sugimachi K. A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism: Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc, 2000, 14(2): 127–130

    CAS  PubMed  Google Scholar 

  22. Surgawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T, Makuuchi M. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg, 2000, 190(4): 446–450

    Article  Google Scholar 

  23. Xiong C L, Wang G Y, Chen X P. Effect of the spleen immune function on hepatocellular carcinoma. J Hepato-biliary Surg, 1994, 2: 253–255

    Google Scholar 

  24. Cao Z X, Chen X P, Wu Z D. A study on Th1/Th2 cytokines immunological condition in the patients with primary hepatocellular carcinoma combined with liver cirrhosis. Chin J Exp Surg, 2001, 18: 518–519

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hepatic Surgery Center, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Jiang Bin MD, Chen Xiaoping MD FACS, Huang Zhiyong MD, Zhang Zhiwei MD, He Songqing MD, Wang Shaofa MD, Wu Zaide MD & Qiu Fazu MD

Authors
  1. Jiang Bin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Xiaoping MD FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huang Zhiyong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhang Zhiwei MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. He Songqing MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wang Shaofa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wu Zaide MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qiu Fazu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chen Xiaoping MD FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, B., Chen, X., Huang, Z. et al. Surgical treatment of hepatocellular carcinoma with cirrhotic esophageal varices and hypersplenism: a 184 case report. Front. Med. China 1, 24–29 (2007). https://doi.org/10.1007/s11684-007-0005-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-007-0005-7

Keywords

Search

Navigation